Hepatitis D Remains Underestimated Threat for Hepatitis B Patients
World Hepatitis Day 2026 highlights the threat of Hepatitis D, the most severe form of chronic viral hepatitis. This underdiagnosed condition affects only patients already infected with Hepatitis B.
On World Hepatitis Day 2026, attention is drawn to Hepatitis D (HDV), recognized as the most severe form of chronic viral hepatitis. The campaign calls for the removal of barriers hindering hepatitis testing, treatment, and care. HDV exclusively affects individuals already infected with Hepatitis B (HBV), significantly worsening the disease's progression.
The severity of Hepatitis D stems from its propensity to rapidly advance to cirrhosis and increase the risk of liver cancer, presenting a hidden danger to affected patient populations. The World Health Organization (WHO) has repeatedly emphasized the necessity of raising awareness and improving access to care to mitigate the impact and spread of HDV.
The campaign serves as a reminder that while Hepatitis B vaccination is effective in preventing HBV infection, it does not offer protection against HDV for those already carrying the virus. Specific diagnostic tests are required to detect HDV infection, and its treatment often involves more complex care pathways.
This year's theme underscores the critical need to ensure that all individuals infected with Hepatitis B receive the necessary testing and treatment. The overarching goal is to reduce the global burden of hepatitis, a burden to which HDV contributes significantly, yet often remains overlooked in global health initiatives.